- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroendocrine Tumors, NET in New Zealand
Total 3447 results
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Italy, United Kingdom, Netherlands, Canada, Germany, Australia, Spain, Switzerland, France
-
Memorial Sloan Kettering Cancer CenterIO BiotechRecruiting
-
Alaunos TherapeuticsCompleted
-
Hoffmann-La RocheRecruitingSmall Cell Lung Cancer | Neuroendocrine CarcinomaUnited States, Japan, Denmark, Spain, Poland
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterSchering-PloughCompletedMelanoma | Cancer | Skin CancerUnited States
-
AttenuonUnknown
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedMelanomaUnited States
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
NYU Langone HealthBristol-Myers SquibbCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Melanoma (Skin)United States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Dermatologic Cooperative Oncology GroupUnknown
-
MapKure, LLCRecruitingSolid Tumor | B-Raf Mutation-Related TumorsUnited States, Australia
-
Eli Lilly and CompanyCompletedMetastatic Malignant MelanomaUnited States
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Point TherapeuticsCompleted
-
Bristol-Myers SquibbCompletedMelanoma | Skin CancerUnited States, Canada, Netherlands, Spain, Australia, Italy, Japan, Germany, Ireland, United Kingdom, Czechia, Switzerland, Poland, France, Greece, New Zealand
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedMelanomaUnited States, France, Italy, United Kingdom, Spain, Belgium, Israel, Mexico, Japan, Canada, Netherlands, Sweden, Korea, Republic of, Australia, Russian Federation, Chile, Germany, Poland, Ireland, New Zealand, Denmark, Switzerland, South Africa
-
Sanjiv Agarwala, MDMerck Sharp & Dohme LLCUnknown
-
Shaheer A. KhanAstraZeneca; Melanoma Research AllianceCompleted
-
Clinigen, Inc.Prometheus LaboratoriesTerminatedMetastatic MelanomaUnited States
-
Columbia UniversityCompleted
-
PfizerTerminatedNeuroblastomaAustralia, Korea, Republic of, United States, Portugal, New Zealand, Sweden
-
ViralyticsProvidence Health & ServicesCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedMelanoma | Acral Melanoma | Mucosal Lentiginous MelanomaUnited States
-
Bristol-Myers SquibbCompletedMelanomaItaly, France, Spain, Australia
-
Memorial Sloan Kettering Cancer CenterCompletedMelanoma | Skin CancerUnited States
-
Hoffmann-La RocheCompleted
-
MedImmune LLCCompletedMelanoma | Malignant Metastatic MelanomaUnited States
-
CancerVax CorporationUnknownMelanoma (Skin)United States, Australia
-
Novartis PharmaceuticalsTerminatedUveal MelanomaUnited States, Australia, France, Netherlands, Spain, Norway
-
NYU College of DentistryGenentech, Inc.CompletedKeratocystic Odontogenic TumorUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedTesticular Germ Cell Tumor | Ovarian Cancer | Brain and Central Nervous System Tumors | Teratoma | Extragonadal Germ Cell TumorUnited States
-
Idera Pharmaceuticals, Inc.CompletedMetastatic MelanomaUnited States
-
Bristol-Myers SquibbMedarexCompletedMelanomaFrance, United States, Australia, Belgium, Germany, South Africa, Canada, Brazil, Czech Republic, Hungary
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Spain, Austria, Italy, Sweden, Russian Federation, Ukraine, Finland, Norway, Poland
-
Anaveon AGRecruitingAdvanced Solid Tumor | Metastatic Melanoma | Melanoma (Skin) | Cutaneous Melanoma | Adult DiseaseUnited States, Spain, Germany, France, Italy
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
AmgenCompletedSarcoma | Lymphoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumors | Metastatic Cancer | Solid Tumors | Carcinoid | Locally AdvancedUnited States, Spain, Poland
-
Cancer Insight, LLCElios Therapeutics, LLCCompleted
-
Advanced Accelerator ApplicationsApproved for marketingNeuroendocrine TumorsUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Genzyme, a Sanofi CompanyCompletedMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.Active, not recruiting
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Australia
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia